Source: International Congress 2014 – Multidrug-resistant (MDR) pathogens that cause pneumonia
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
G. Dimopoulos (Athens, Greece). MDR pathogens in the ICU: the magnitude of the problem. International Congress 2014 – Multidrug-resistant (MDR) pathogens that cause pneumonia

Member's Comments

No comment yet.

Related content which might interest you: How do I control transmission of MDR organisms in and out the ICU? Source: Annual Congress 2013 –PG3 Infections and critical patients: emerging problems and clinical strategies Year: 2013 Are multi-drug resistant (MDR) pathogens related to higher mortality in pneumonia? Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011 Identifying patients with pneumonia due to MDR organisms coming from the community Source: Eur Respir Monogr 2017; 75: 97-110 Year: 2017 High carbapenem resistance in gram negative bacterial isolates: An outcome study Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013 Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017 Frequency of risk factors for multi-drug resistant tuberculosis among the patients enrolled at multi-drug resistant clinic in a tertiary care hospital, Pakistan Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014 Is health care-associated pneumonia itself a predisposing factor for multi-drug resistant organisms? Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019 Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosis Source: Eur Respir J 2015; 45: 1353-1363 Year: 2015 MDR pathogens: definitions, mechanisms and risk factors Source: International Congress 2015 – PG14 Antibiotic stewardship for respiratory infections Year: 2015 Hospital-acquired pneumonia: microbiological data and potential adequacy of antimicrobial regimens Source: Eur Respir J 2002; 20: 432-439 Year: 2002 Poor prediction of potentially drug-resistant pathogens using current criteria of health care-associated pneumonia Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012 VAP: approach to therapy Source: Eur Respir Mon 2011; 53: 36-47 Year: 2011 International guidelines for nosocomial pneumonia: do they cover multidrug resistance management? Source: International Congress 2019 – Multidrug resistance in nosocomial pneumonia: burden, magnitude and solution Year: 2019 Prevalence of relevant multi-drug resistant (MDR) pathogens in a bronchiectasis (BE) cohort. Source: International Congress 2019 – Complex respiratory infections in clinical practice Year: 2019 The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting Source: Annual Congress 2003 - Epidemiology, therapy and outcome of infections in the ICU Year: 2003 Study of drug resistance profile in Multidrug resistant tuberculosis (MDR TB) patients attending a tertiary care hospital at Mumbai. Source: International Congress 2017 – TB: diagnosis, severity and practical management Year: 2017 Resistant pathogens that cause pneumonia: a global perspective Source: International Congress 2014 – Multidrug-resistant (MDR) pathogens that cause pneumonia Year: 2014 Predicting bacteraemia or rapid identification of the causative pathogen in community acquired pneumonia: where should the priority lie? Source: Eur Respir J 2016; 48: 619-622 Year: 2016 Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review Source: Eur Respir J 2008; 31: 625-632 Year: 2008